What is the price of a box of everolimus in China in 2024?

Everolimus has been launched in China and has been included in the scope of medical insurance. Patients can go to local hospitals for consultation and purchase. According to the latest data, the domestic price of the drug is approximately 2,000-4,000 yuan. In addition to the original drug everolimus, legal generic drugs also exist in India, and their drug ingredients are basically the same as the original drug. These generic drugs undergo compliant production processes and comply with relevant regulations and quality standards. It is understood that the latest prices of these generic drugs currently range from a few hundred to 1,500 yuan.

Everolimus is a drug that inhibits mTOR activation and has the effects of inhibiting cell proliferation, angiogenesis and glucose uptake. mTOR (mammalian target of rapamycin) is a signaling pathway that plays a key role in cell proliferation, growth and metabolism. In a variety of tumors, the mTOR signaling pathway is often abnormally activated, promoting tumor development. Everolimus inhibits the growth and proliferation of tumor cells by inhibiting the activity of mTOR.

Everolimus is not only used in the treatment of renal cell carcinoma, but is also widely used in the treatment of various other tumors. For example, everolimus has also shown significant therapeutic effects in subependymal giant cell astrocytoma that cannot be curatively resected. In addition, everolimus has also been proven to be an effective therapeutic drug in the treatment of various cancers such as breast cancer and pancreatic neuroendocrine tumors.

For patients who need to use everolimus for treatment, they can choose to purchase the original drug or legal generic drug according to their own circumstances. No matter which drug is chosen, it needs to be used rationally under the guidance of a doctor, and reviewed and monitored regularly. For price considerations, patients can consult a doctor or go to multiple hospitals to compare and choose a drug that meets their financial affordability.